Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults

Gerontology

Volumn 55, Issue 1, 2009, Pages 32-40

  Sawyer, Kathryn ^a   Sachs Ericsson, Natalie ^a   Preacher, Kristopher J ^b   Blazer, Dan G ^c  

^a FLORIDA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

APOE genotype; Cognitive decline; Racial differences, APOE epsilon 4 allele

Indexed keywords

APOLIPOPROTEIN E;

AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; COMMUNITY SAMPLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; TECHNIQUE;

AFRICAN AMERICANS; AGE FACTORS; AGED; ALLELES; APOLIPOPROTEIN E4; COGNITION DISORDERS; DEMENTIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 59749097239     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000137666     Document Type: Article

References (44)

1. Fillenbaum GG, Landerman LR, Blazer DG, Saunders AM, Harris TB, Launer LJ: The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. J Am Geriatr Soc 2001;49:1148-1155.
2. Howieson DB, Camicioli R, Quinn J, Silbert LC, Care B, Moore MM, Dame A, Sexton G, Kaye JA: Natural history of cognitive decline in the old old. Neurology 2003;60:1489-1494.
3. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133-1142.
4. Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC: Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry 2003;182:449-454.
5. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH: Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Part 1. Arch Neurol 2003;60:1385-1389.
6. Lopez OL, Kuller LH, Becker JT, Dulberg C, Sweet RA, Gach HM, DeKosky ST: Incidence of dementia in mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Arch Neurol 2007;64:416-420.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
8. Roses AD: Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437.
9. Strittmatter WJ, Saunders AM, Schmechel DE, Pericak-Vance MA, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
10. Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, Andrews H, Feng L, Tycko B, Mayeux R: The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998;279:751-755.
11. Evans DA, Bennett DA, Wilson RS, Bienias JL, Morris MC, Scherr PA, Hebert LE, Aggarwal N, Beckett LA, Joglekar R, Berry-Kravis E, Schneider J: Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol 2003;60:185-189.
12. Tycko B, Lee JH, Ciappa A, Saxena A, Li CM, Feng L, Arriaga A, Stern Y, Lantigua R, Shachter N, Mayeux R: APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals. Arch Neurol 2004;61:1434-1439.
13. Green RC, Cupples LA, Go R, Benke KS, Edeki T, Griffith PA, Williams M, Hipps Y, Graff-Radford N, Bachman D, Farrer LA; MIRAGE Study Group: Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA 2002;287:329-336.
14. Ioannidis JP, Trikalinos TA, Khoury MJ: Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol 2006;164:609-614.
15. Teresi JA, Kleinman M, Ocepek-Welikson K: Modern psychometric methods for detection of differential item functioning: application to cognitive assessment measures. Stat Med 2000;19:1651-1683.
16. Lee S, Kawachi I, Berkman LF, Grodstein F: Education, other socioeconomic indicators, and cognitive function. Am J Epidemiol 2003;157:712-720.
17. Fillenbaum G, Heyman A, Williams K, Prosnitz B, Burchett B: Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. J Clin Epidemiol 1990;43:651-660.
18. Gurland BJ, Wilder DE, Cross PE, Teresi JA, Barrett VW: Screening scales for dementia: toward reconciliation of conflicting cross-cultural findings. Int J Geriatr Psychiatry 1992;7:105-113.
19. Lyketsos CG, Chen LS, Anthony JC: Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area Study. Am J Psychiatry 1999;156:58-65.
20. Miles TP, Froehlich TE, Bogardus ST, Inouye SK: Dementia and race: are there differences between African Americans and Caucasians? J Am Geriatr Soc 2001;49:477-484.
21. Demirovic J, Prineas R, Loewenstein D, Bean J, Duara R, Sevush S, Szapocznik J: Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol 2003;13:472-478.
22. Sachs-Ericsson N, Blazer DG: Racial differences in cognitive decline in a sample of community-dwelling older adults: the mediating role of education and literacy. Am J Geriatr Psychiatry 2005;13:968-975.
23. Blazer DG, Landerman LR, Hays JC, Grady TA, Havlik R, Corti M: Blood pressure and mortality risk in older people: comparison between African Americans and whites. J Am Geriatr Soc 2001;49:375-381.
24. Murrell JR, Price B, Lane KA, Baiyewu O, Gureje O, Ogunniyi A, Unverzagt FW, Smith-Gamble V, Gao S, Hendrie HC, Hall KS: Association of apolipoprotein E genotype and Alzheimer disease in African Americans. Arch Neurol 2006;63:431-434.
25. Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA: Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Arch Neurol 2002;59:594-600.
26. Perry RT, Collins JS, Harrell LE, Acton RT, Go RC: Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 2001;105:332-342.
27. Cornoni-Huntley J, Blazer D, Lafferty M, Everett D, Brock D, Farmer M (eds): Established Populations for Epidemiologic Studies of the Elderly: Resource Data Book. Bethesda, National Institute on Aging, 1990.
28. Pfeiffer E: A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433-441.
29. Rosow I, Breslau N: A Guttman health scale for the aged. J Gerontol 1966;21:556-559.
30. Douglas CE: Mortality differences by APOE genotype estimated from demographic synthesis. Genet Epidemiol 2002;22:146-155.
31. Rasbash J, Steele F, Browne W, Prosser B: A User's Guide to MLwiN Version 2.0. Bristol, University of Bristol, 2005.
32. Singer JD, Willett JB: Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York, Oxford University Press, 2003.
33. DeKosky ST, Marek K: Looking backward to move forward: early detection of neurodegenerative disorders. Science 2003;302:830-834.
34. Stewart R, Russ C, Richards M, Brayne C, Lovestone S, Mann A: Depression, APOE genotype and subjective memory impairment: a cross-sectional study in an African-Caribbean population. Psychol Med 2001;31:431-440.
35. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, Kukull W: Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006;144:73-81.
36. Spangler JG, Konen JC: Predicting exercise and smoking behaviors in diabetic and hypertensive patients. Age, race, sex, and psychological factors. Arch Fam Med 1993;2:149-155.
37. Lewis TT, Everson-Rose SA, Sternfeld B, Karavolos K, Wesley D, Powell LH: Race, education, and weight change in a biracial sample of women at midlife. Arch Intern Med 2005;165:545-551.
38. Gary TL, Baptiste-Roberts K, Gregg EW, Williams DE, Beckles GL, Miller EJ 3rd, Engelgau MM: Fruit, vegetable and fat intake in a population-based sample of African Americans. J Natl Med Assoc 2004;96:1599-1605.
39. Reusser ME, McCarron DA: Reducing hypertensive cardiovascular disease risk of African Americans with diet: focus on the facts. J Nutr 2006;136:1099-1102.
40. Markides KS, Martin HW: Predicting self-related health among the aged. Res Aging 1979;1:97-112.
41. Pettit JW, Kline JP, Gencoz T, Gencoz F, Joiner TE: Are happy people healthier? The specific role of positive affect in predicting self-reported health symptoms. J Res Pers 2001;35:521-536.
42. Pettit T, Livingston G, Manela M, Kitchen G, Katona C, Bowling A: Validation and normative data of health status measures in older people: the Islington Study. Int J Geriatr Psychiatry 2001;16:1061-1070.
43. Mossey JM, Shapiro E: Self-rated health: a predictor of mortality among the elderly. Am J Public Health 1982;71:800-808.
44. Fillenbaum GG, Blazer DG, Burchett BM, Saunders AM, Taylor DH Jr: Apolipoprotein Eε4 and risk of mortality in African American and white older community residents. Gerontologist 2002;42:381-386.